NEOSTIGMINE METHYLSULFATE INJECTION, USP
Google image searchProduct monograph
Active ingredient
neostigmine methylsulfate, 0.5 MG/ML
DIN: 02537516
Dosage form(s): SOLUTION
Route(s) of administration: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 28-MAR-2024
ATC:
- N07 — OTHER NERVOUS SYSTEM DRUGS (ATC, ATC/DDD, )
- N07A — PARASYMPATHOMIMETICS (ATC, ATC/DDD)
- N07AA — Anticholinesterases (ATC, ATC/DDD)
- N07AA01 — NEOSTIGMINE (ATC/DDD)
Reference brand drug: Prostigmin
Pharmaceutical standard: USP
